510(k) K925355

BIOSIGN(TM_ RUBELLA - RUBELLA ANTIBODY TEST by Princeton Biomedix — Product Code LFX

K925355 is an FDA 510(k) premarket notification submitted by Princeton Biomedix for the device "BIOSIGN(TM_ RUBELLA - RUBELLA ANTIBODY TEST". The FDA issued a decision of Substantially Equivalent on July 12, 1994. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Princeton Biomedix has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 12, 1994
Date Received
October 22, 1992
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class
Class II
Regulation Number
866.3510
Review Panel
MI
Submission Type